A method and guidance system for detecting risks in endotracheal intubation procedures

By acquiring batch performance data of endotracheal intubation, and combining it with the requirements of its intended use and operational stage, operational risks are calculated and usage guidelines are generated. This solves the problem of risk prediction and management for endotracheal intubation under different uses and operational stages, and improves the accuracy and efficiency of operational preparation.

CN123120201APending Publication Date: 2026-11-17JIANGXI BAOKANG MEDICAL EQUIP CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611420722.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-14
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing endotracheal tubes, due to their different uses and operational stages, cannot take advantage of the performance differences between qualified batches to predict operational risks in advance and provide corresponding usage guidance, making it difficult to predict and manage operational risks.

Method used

By obtaining evaluation values ​​of the outer diameter, bending radius, and stiffness of endotracheal tubes of the same product line and nominal specifications, batch performance deviations are identified. Combined with the needs of different uses and operational stages, operational risks are calculated, and usage guidance plans are generated, including softening, shaping, and guidance-assisted treatments.

Benefits of technology

It improved the application matching ratio, reduced the maximum residual risk and cumulative residual risk, reduced additional processing time, and improved the accuracy and efficiency of operational preparation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123120201A_ABST
    Figure CN123120201A_ABST
Patent Text Reader

Abstract

This invention discloses a method and guidance system for detecting and guiding risks in endotracheal intubation procedures. It acquires the actual outer diameter, actual bending radius, and tube stiffness evaluation values ​​of multiple qualified production batches under the same product line and nominal specifications. Based on product settings and allowable tolerances, it generates batch performance deviation states. For different optional uses and operational stages, the batch performance deviation states are converted into performance scores, forming an operational risk sequence. Based on the operational risks, a usage method correction scheme is generated, the corrected risks are recalculated, and the usage method for each batch is determined by combining the maximum residual risk, cumulative residual risk, and handling burden. Further usage guidance is generated, and risk changes are recalculated. When there are batch selection or usage allocation requirements, the usage priority is determined accordingly. This invention can utilize the performance dispersion between qualified batches to refine the detection of operational risks under different uses and provide corresponding usage guidance.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of medical device data processing technology, and in particular to a method and guidance system for detecting risks during endotracheal intubation. Background Technology

[0002] Endotracheal tubes are widely used for airway establishment and ventilation support. For endotracheal tubes of the same product line and nominal specifications, the production process typically involves inspecting indicators such as outer diameter, material hardness, and bending performance according to relevant technical requirements, and determining whether the product is qualified based on the specified allowable range.

[0003] Even if different production batches all meet the product qualification requirements, their actual outer diameter, bending radius, and pipe stiffness may still fall within different ranges of allowable tolerance. The existing inspection process is mainly used to determine whether a product is qualified; for different production batches that have already been determined to be qualified, further differentiation based on their specific performance conditions is usually not conducted.

[0004] However, the requirements for channel passage, bending adaptation, and directional navigation vary depending on the application and stage of the procedure. The same performance deviation can have different effects depending on the application or stage of the procedure; for example, lower stiffness may be beneficial for partial bending operations, while higher stiffness may be beneficial for maintaining the propulsion direction.

[0005] The current methods of using endotracheal intubation are mainly determined based on product specifications, operational requirements, and user experience. It is difficult to further utilize the existing performance differences between qualified batches to predict the operational risks that a particular batch may encounter in specific uses and operational stages. It is also difficult to determine the corresponding softening, shaping, or guidance assistance methods and their processing times. Furthermore, it is difficult to explain the risks that may increase if the corresponding treatment is not provided.

[0006] Therefore, it is necessary to utilize the existing performance data from different qualified production batches to test the operational risks under different uses and operating stages, and to develop corresponding usage guidelines. Summary of the Invention

[0007] This invention discloses a method for detecting risks during endotracheal intubation, comprising the following steps:

[0008] S1. Obtain the final inspection information and production traceability information of endotracheal tubes of the same product line and nominal specifications that have passed the final inspection, and generate performance data according to production batches.

[0009] Required performance data includes: 1. The actual inner and outer diameter of the pipe body; 2. Actual bending radius of the pipe body; 3. Evaluation of pipe stiffness.

[0010] The actual outer diameter and actual bending radius of the pipe are obtained from existing test data in the final inspection or factory inspection process, and the test caliber follows the corresponding product technical requirements or inspection specifications. The actual inner diameter of the pipe is preferably obtained from the final inspection data; when the final inspection record includes the outer diameter of the starting end, middle end, and ending end, the representative value of the outer diameter is preferably weighted at a ratio of 1:4:1 for the starting end, middle end, and ending end, and the representative value of the inner diameter is preferably the average value of the starting end and ending end.

[0011] Based on production traceability information, obtain the Shore A hardness test value of the raw materials corresponding to the current product. The preferred approach is to use the semi-empirical conversion relationship between Shore A hardness and Young's modulus proposed by Gent to convert Shore A hardness into equivalent elastic modulus:

[0012] in, The equivalent elastic modulus is expressed in MPa; the preferred conversion relationship applies to... The range of Shore A hardness values.

[0013] Furthermore, the tube stiffness evaluation quantity is formed based on the equivalent elastic modulus and the actual cross-sectional dimensions of the tube:

[0014] in, , These are the representative values ​​of the actual outer diameter and the actual inner diameter of the current product, respectively. , These are the corresponding product's outer and inner design diameters, respectively. To obtain the equivalent elastic modulus of the product by substituting the Shore A hardness of the raw materials used in the product design into the aforementioned conversion relationship; This refers to the dimensionless tube stiffness evaluation quantity relative to the design state. .

[0015] For each product within the same production batch, the actual outer diameter, actual bending radius, and tube stiffness evaluation values ​​are statistically analyzed, and the median is preferably used as the batch representative value for the corresponding performance.

[0016] The performance data tuple for the current production batch is formed by the batch representative values ​​of the actual outer diameter, the actual bending radius, and the tube stiffness evaluation value.

[0017] S2. Output batch performance deviation status

[0018] Read the batch performance data tuple generated by S1, as well as the product setting values ​​and allowable tolerances corresponding to each performance level under the same product line and nominal specification.

[0019] For the evaluation parameters of actual outer diameter, actual bending radius, and pipe stiffness, determine the corresponding product setting values ​​respectively. Qualified lower limit and the upper limit of qualification For the tube stiffness evaluation quantity, the corresponding design parameters and their allowable boundaries are substituted into the same calculation relationship of S1 to obtain its set value and allowable range.

[0020] Preferably, the lower and upper limits of the equivalent elastic modulus of the raw materials are respectively... and The actual lower and upper limits of the outer diameter are respectively and The actual lower limit and upper limit of the inner diameter are respectively and Then the lower and upper limits of the allowable stiffness evaluation quantity of the pipe body are respectively:

[0021]

[0022] in, and The lower and upper limits of the allowable Shore A hardness of the raw material are obtained through the same conversion relationship of S1.

[0023] Calculate the normalized performance offset for each energy level:

[0024] in, This is the batch representative value of the performance quantity corresponding to the current batch; This indicates a downward offset relative to the set value. Indicates upward offset. This indicates the degree of deviation relative to the corresponding allowable tolerance.

[0025] The performance deviation state of the current production batch is formed by the normalized performance offset corresponding to each energy level.

[0026] S3. Output operational risks based on performance deviations and optional uses.

[0027] Based on the performance deviation status obtained from S2, and combined with the stage requirements of different uses and operating processes, the performance status of the current production batch is converted into operational risk.

[0028] Pre-establish optional uses and corresponding operating procedures. Optional uses include, but are not limited to, oral intubation and nasal intubation. For each use, divide the operation into multiple stages based on the actual advancement process, and assign a specific stage to each stage. Each operational phase is configured with channel throughput requirements, curvature adaptation requirements, and directional navigation requirements.

[0029] Demand levels are represented from 0 to 3, where:

[0030] A preferred configuration method for basic requirements is as follows:

[0031] Furthermore, the corresponding demand level is modified based on the currently adopted additional operational procedures. Optional additional operational procedures include autonomous orientation, typesetting assistance, and guidance assistance. A preferred demand modification amount is as follows:

[0032] Each demand component is adjusted separately, and the adjusted demand level is limited to the range of level 0 to level 3.

[0033] Furthermore, configure the performance items and favorable directions corresponding to each requirement:

[0034] For performance terms whose values ​​increase or decrease unidirectionally, indicating improved performance, the normalized performance offset of S2 is used. Convert to a degree of performance benefit; for performance items that indicate an improvement in performance close to the reference bending state, the corresponding reference bending radius and its allowable range are used for evaluation:

[0035] in, The degree of performance advantage of the current performance item; This represents the actual bending radius of the current batch. The reference bending radius for evaluation in the current application; , These represent the lower and upper limits of the allowable bending state, respectively.

[0036] When no additional reference bending condition is specified for a specific application or operational phase, directly call the product setting value and allowable range corresponding to the bending radius in S2, and set:

[0037] Therefore, all operational stages can use the design bending state of the same specification product as a default reference, while differences between stages are determined by the corresponding demand levels. express.

[0038] When the product instruction manual, operating specifications, product design documents, or other intended-purpose parameters have specified an independent reference bending state for a particular purpose or operating stage, the aforementioned default value shall be replaced by the independently specified target bending radius and allowable range.

[0039] Limits are applied to the results of any of the aforementioned advantage calculations:

[0040] This keeps the performance advantage within the range of 0 to 1.

[0041] Performance benefits Actual performance ratings are converted to levels 0 through 3 based on a fixed threshold:

[0042] For the The first operational phase For each requirement, calculate the actual performance score for each performance item corresponding to that requirement, and take the lowest score as the actual performance score for that requirement. .in, These represent the three requirements: passageway access, curvature adaptation, and directional navigation.

[0043] The revised demand level Corresponding actual performance score By comparing, we obtain the first The first operational phase Operational risks associated with this requirement:

[0044] The three demand risks in the same operation phase form the phase risk, and the initial risk sequence corresponding to the current use and operation process is formed according to the order of the operation phases.

[0045] S4. Develop usage guidelines based on operational risks and output processing burdens.

[0046] Read the initial risk sequence formed by S3 and generate a limited number of candidate usage guidelines based on the type and degree of non-zero risk.

[0047] A preferred configuration is as follows: A pre-established correspondence between risk types and permitted modification methods is established.

[0048] When multiple non-zero risks exist in the same operational phase, the permissible correction methods corresponding to each risk are read separately, and a finite number of non-repeating and non-mutually exclusive combinations are enumerated to form candidate usage guidance schemes. For mutually exclusive additional operational processes, only one of them is retained in the same candidate scheme. Preferably, in this evaluation process, autonomous directional propulsion, shaping assistance, and guidance assistance are mutually exclusive choices as replaceable additional operational modes in the same operational phase; softening processing can be combined with any of these additional operational modes.

[0049] The softening treatment is set to a limited number of predetermined softening levels. The relationship between the softening level and the stiffness state is obtained through pre-calibration. The preferred calibration method is as follows: representative products from the same product line and with the same nominal specifications are selected, and the pipe stiffness evaluation values ​​before and after softening are obtained in the unsoftened state and at each predetermined softening level. The median ratio of the stiffness evaluation value after softening to the stiffness evaluation value before softening at the same level is used as the stiffness correction coefficient for that softening level. .

[0050] For the current batch, the first For each softening level, the corrected stiffness evaluation value is:

[0051] in, Indicates an unsoftened state. As the degree of softening increases, The values ​​decrease sequentially. The calibration is only used to obtain the mapping relationship between softening level and performance state, and does not limit the specific softening process.

[0052] For candidate schemes involving switching additional operation processes, the corresponding requirement correction amount for the additional operation process in S3 is invoked; for candidate schemes involving softening processing, the corrected stiffness evaluation amount is used. Substitute into S3. Therefore, apply all modifications to each candidate application guidance scheme at once, and recalculate each step according to the original operational sequence. This forms the corresponding revised risk sequence.

[0053] For the For each of the candidate solutions, calculate the maximum residual risk, cumulative residual risk, and processing burden:

[0054] in, Indicates the first candidate solution An additional processing step, For the first The number of additional processing actions included in each candidate solution The additional operation time for this processing action relative to the original operation process is preferably measured in seconds. The additional operation time is preferably obtained by taking the median of existing operation records for the same processing action; if no existing records exist, it is obtained through pre-timed operation.

[0055] Determine the usage guidelines for the current batch for its designated purpose in the following order: 1. Priority Selection Lower number of candidate solutions; 2. When When the two are the same, choose the one that takes precedence. Lower number of candidate solutions; 3. When both of the above two options are the same, the option with priority shall be selected. Lower number of candidate solutions.

[0056] Output the determined usage guidelines, the revised risk sequence, and the corresponding handling burden.

[0057] S5. Prioritize batch usage and provide usage guidance recommendations.

[0058] Read the usage method, pre-correction risk sequence, post-correction risk sequence, maximum remaining risk, cumulative remaining risk, and processing time corresponding to each usage method correction generated by S4 for each production batch and each optional use.

[0059] For the current production batch and its intended use, the usage method is modified according to the actual time period, and divided into pre-operation processing and operation process processing.

[0060] Pre-operative treatment includes softening and pre-shaping, which are completed before the endotracheal intubation procedure. The operation process includes guidance and assistance, as well as other additional operations that need to be completed at the corresponding operation stage.

[0061] Accumulate the time added before the operation and the time added during the operation separately:

[0062] in, This indicates the additional processing time before the actual operation. This indicates the additional processing time during the intubation procedure. This indicates the total processing load.

[0063] Furthermore, the pre-correction risk sequence formed by S3 and the post-correction risk sequence formed by S4 are matched step by step to determine the main risk stage, risk type, and remaining risk after correction using the corresponding application method under the current application.

[0064] For a given operational phase, if the pre-correction demand risk is Level 1, it is treated as a general operational risk; if the pre-correction demand risk is Level 2 or Level 3, it is treated as a major operational risk.

[0065] For each non-zero risk, output its operational stage, risk type, corresponding usage method correction, and the remaining risk after correction.

[0066] When the corresponding correction belongs to pre-processing, the output shows the processing method, processing degree, and expected increase in pre-processing time; when the corresponding correction belongs to process processing, the output shows the operation stage that needs to be added, the additional operation process, and the expected increase in process time.

[0067] Furthermore, the impact of the missing features on each of the modifications to the usage methods already determined for the current application is evaluated.

[0068] For any modification in the usage method The correction is cancelled, while the remaining corrections and batch performance data remain unchanged. The risk sequence missing this correction is then reconstructed according to the same risk calculation rules as S3.

[0069] For modifications used to replace the original operation process, canceling the modification restores the original operation process before S4 generated the candidate solution.

[0070] Correct missing information Comparison of risks after use with risks under the full usage scenario:

[0071] in, Indicates the complete usage method. Operational Phase The residual risk corresponding to demand Indicates missing correction The corresponding risks, This indicates the increased risk caused by the absence of this correction.

[0072] when When the risk increases, output the operational stage, risk type, and increase level, and simultaneously output the pre-operation time or operational time that could be reduced by omitting this correction. Explain the time currently occupied by the processing and the corresponding risk arising from the omission of this processing.

[0073] Therefore, complete usage instructions are developed for each optional application within the same production batch. The usage instructions for each application include at least: 1. Current purpose and corresponding usage; 2. Key risk stages and risk types before revision; 3. The required modifications to the usage methods and the extent of those modifications; 4. Additional processing time before operation; 5. The increased processing time and corresponding operation stages during the operation; 6. Revised maximum residual risk, cumulative residual risk, and risk sequence for each operational stage; 7. The risk stages, risk types, and risk levels that increase when various usage methods are corrected or missing; 8. Omit the processing time that can be reduced by the corresponding correction.

[0074] Once the usage guidelines for each of the above purposes have been developed, the priority of use will be further determined only when there is a need for batch selection or purpose allocation.

[0075] When the intended use is determined and multiple production batches are available, the production batches are compared in the order of maximum residual risk, cumulative residual risk, process handling time, and total processing burden. Processing time is only used to determine the order when the risk assessment results are the same.

[0076] When it is necessary to prioritize the allocation of multiple uses for the same production batch, the usage guidelines already established for each use of the production batch are compared in the same order.

[0077] If there is no need for batch selection or usage allocation, the usage guidance results corresponding to each usage will be retained, and usage priority will not be formed.

[0078] Therefore, the performance dispersion of different qualified production batches is further converted into usage methods, risk occurrence stages, processing periods, expected times, and risk changes after processing are corresponding to each application, and the usage priority order of batches or applications is further provided when there is an actual selection need.

[0079] The beneficial effects of this invention are: (1) By obtaining the outer diameter, bending radius and tube stiffness evaluation quantities of different qualified production batches under the same product line and the same nominal specifications, and forming the batch performance deviation state, the batch performance discrete within the qualified tolerance range can be used to evaluate the application adaptability, which can improve the application matching ratio of low processing load batches.

[0080] (2) By matching the performance deviation of batches with the performance requirements of different uses and operation stages, and forming operational risks based on insufficient demand, the present invention can identify the performance shortcomings of each production batch in specific operation stages in advance, thereby reducing the maximum residual risk and the cumulative residual risk.

[0081] (3) By generating a limited set of usage method modification schemes based on operational risks and determining usage guidance schemes in combination with the modified risks and processing burdens, the present invention can reduce unnecessary softening, shaping and guidance assistance, and reduce additional processing time;

[0082] (4) By outputting the risk occurrence stage, the method of use correction, and the expected processing time before and during the operation, the present invention can remind users in advance of the preparation and auxiliary operations that need to be performed, thereby reducing on-site ad-hoc judgment and adjustment;

[0083] (5) By unifying batch performance, application risks, processing methods and corresponding times into a unified usage guidance result, this invention can improve the accuracy of the selection of different qualified batches for use and operation preparation, facilitate the advance arrangement of batch use, softening treatment and auxiliary operation periods, and submit them to the external planning system to improve the work efficiency of operators.

[0084] The present invention also provides a risk guidance system for endotracheal intubation procedures, used to perform the above-mentioned risk detection method for endotracheal intubation procedures, comprising: The data acquisition module is used to acquire batch performance data of different qualified production batches; The performance deviation determination module is used to generate batch performance deviation status based on product settings and allowable tolerances. The operational risk detection module is used to convert the performance deviation of the batch into operational risks based on different uses, operational stages and corresponding performance requirements. The usage method determination module is used to generate and evaluate usage method modification schemes based on the operational risks, and to determine the usage method of each production batch under each purpose. The guidance output module is used to output the risk stage, usage method correction, processing time, remaining risk, and risk changes after missing usage method correction for each application, and output the usage priority order of batch or application when there is a selection requirement.

[0085] The guidance system includes a processor and a memory. The memory stores a computer program, which, when executed by the processor, implements the above-mentioned risk detection method for endotracheal intubation. Attached Figure Description

[0086] Figure 1 This is a schematic diagram of the process of the present invention.

[0087] Figure 2 This is a diagram of the main interface of a software developed according to the process described in this invention. It is used to display and browse the current production status.

[0088] Figure 3This is a schematic diagram of an evaluation label for software developed according to the process of this invention. It is used to display the tolerance zone of the test data corresponding to a specific batch of products.

[0089] Figure 4 This is a schematic diagram illustrating the application evaluation of software developed according to the process of this invention. It is used to evaluate the adaptability of a specific batch of products to various usage methods. Detailed Implementation Example 1

[0090] In this embodiment, the performance of endotracheal tube production batches of the same product line, with the same nominal specifications, and all of which have passed final inspection are evaluated to form a batch performance deviation status for subsequent use evaluation.

[0091] In this embodiment, the nominal inner diameter of the endotracheal tube is 7.0 mm, the designed outer diameter is 9.60 mm, and the allowable range is 9.45–9.75 mm; the designed inner diameter is 7.00 mm, and the allowable range is 6.90–7.10 mm; the raw material used in the product design has a Shore A hardness of 80, and the allowable range is 78–82; the product design bending radius is 140 mm, and the allowable range is 120–160 mm.

[0092] The above parameters are obtained from the corresponding product design documents, product technical requirements, and factory inspection requirements.

[0093] Select production batches A, B, and C that have been produced continuously and have all passed final inspection, and read the final inspection information and production traceability information corresponding to each production batch.

[0094] The final inspection information includes the actual outer diameter, actual inner diameter, and actual bending radius of the pipe body, while the production traceability information includes the corresponding raw material batch and the Shore A hardness test value of the raw material.

[0095] For multiple products within the same production batch, the actual outer diameter, actual inner diameter, and actual bending radius of the pipe body are statistically analyzed, and the median is used as the representative value of the performance corresponding to the current production batch.

[0096] The batch representative data obtained in this embodiment is as follows:

[0097] Furthermore, the Shore A hardness of the raw materials corresponding to each production batch is converted into the equivalent elastic modulus.

[0098] This embodiment adopts the semi-empirical conversion relationship between Shore A hardness and Young's modulus proposed by Gent:

[0099] in, This refers to the Shore A hardness of the raw materials corresponding to the current production batch. This is the equivalent elastic modulus, expressed in MPa.

[0100] Substituting the Shore A hardness of 80 used in the product design into the above conversion relationship:

[0101] For batch A, substitute its raw material Shore A hardness of 78.5 into the above conversion relationship:

[0102] For batch B:

[0103] For batch C:

[0104] Furthermore, the representative values ​​of the outer diameter and inner diameter of each batch are read, and the stiffness evaluation quantity of the pipe body is calculated according to the stiffness evaluation relationship in S1.

[0105] Batch A is:

[0106] Batch B is:

[0107] Batch C is:

[0108] Therefore, we can conclude that:

[0109] Among them, the raw material hardness and cross-sectional state of batch A are generally shifted towards lower stiffness, batch B is close to the product design state, and batch C is generally shifted towards higher stiffness.

[0110] Thus, performance data tuples for batch A, batch B, and batch C are formed respectively, and the performance data tuples include representative values ​​of outer diameter, bending radius, and stiffness evaluation.

[0111] Subsequently, based on the product setting values ​​and corresponding allowable tolerances, the fixed evaluation range for each performance quantity is determined.

[0112] In this embodiment, the actual outer diameter is set to 9.60 mm, with a acceptable range of 9.45 to 9.75 mm; the actual bending radius is set to 140 mm, with a acceptable range of 120 to 160 mm.

[0113] For the stiffness evaluation of the pipe body, the allowable boundaries corresponding to the hardness of the raw material, the outer diameter, and the inner diameter are substituted into the same stiffness evaluation relationship as S1 to determine the allowable range of the stiffness evaluation quantity.

[0114] Let the lower and upper limits of the equivalent elastic modulus of the raw materials be respectively... and The lower and upper limits of the outer diameter are respectively and The lower and upper limits of the inner diameter are respectively and .

[0115] Substituting the lower limit of Shore A hardness (78) and the upper limit of Shore A hardness (82) into the Gent relation:

[0116]

[0117] The lower limit of the allowable stiffness evaluation quantity is:

[0118] The upper limit of the allowable stiffness evaluation quantity is:

[0119] This yields the fixed evaluation ranges for the three performance energies in this embodiment:

[0120] Furthermore, the normalized performance offset was calculated for each performance characteristic of the three production batches.

[0121] For any energy, its batch representative value is Product setting value The lower limit of qualification is The upper limit of the qualified level is ,but:

[0122] In this embodiment, the outer diameter of batch A is 9.52 mm, which is less than the set outer diameter value of 9.60 mm. Therefore:

[0123] The representative value for the bending radius of batch A is 130 mm, therefore:

[0124] For the stiffness evaluation of batch A:

[0125] Further calculations are performed for batch B:

[0126]

[0127]

[0128] Calculate for batch C:

[0129]

[0130]

[0131] In the above calculations, the intermediate results of each equivalent elastic modulus and stiffness evaluation quantity are retained to at least three decimal places. When entering the subsequent normalized performance offset calculation, the untruncated calculated values ​​are used. Only when displaying tables and text, three decimal places are retained. This avoids batches near the scoring threshold being incorrectly classified into adjacent levels due to continuous rounding.

[0132] In cases where multiple raw material hardness test records exist within the same batch, the actual raw material records used in the production of that batch should be determined first based on the production traceability relationship, and then representative values ​​should be generated for records from the same source.

[0133] The upper and lower boundaries of the stiffness evaluation quantity adopt a combination of parameter boundaries that can respectively form the minimum and maximum cross-sectional bending stiffness. Therefore... Corresponding to lower material modulus, smaller outer diameter, and larger inner diameter, This corresponds to a higher material modulus, a larger outer diameter, and a smaller inner diameter.

[0134] This results in three performance deviation states corresponding to the production batches:

[0135] Among them, the outer diameter, bending radius and stiffness evaluation values ​​of batch A are generally located at the lower side of the design state; the energy properties of batch B are generally close to the design state; and the energy properties of batch C are generally located at the higher side of the design state.

[0136] The performance deviation is used to represent the actual positional differences between different qualified production batches within a fixed product performance space.

[0137] This embodiment ultimately outputs the performance data tuples and performance deviation status corresponding to batch A, batch B, and batch C, which serve as inputs for application requirement matching and operational risk calculation in Embodiment 2. Example 2

[0138] This embodiment builds upon the performance deviations of batches A, B, and C established in Embodiment 1, further illustrating how performance deviations of different qualified production batches can lead to corresponding operational risks based on specific uses, operational stages, and additional operational processes.

[0139] In this embodiment, the optional application is transoral cannulation, and the corresponding operation process is divided into the stage of entering the restricted channel, the direction adjustment stage, and the target position advancement stage.

[0140] Based on the main operational requirements to be completed at each stage, pre-configure the channel passage requirements, curvature adaptation requirements, and directional navigation requirements.

[0141] This embodiment uses the following basic configuration requirements:

[0142] Level 0 indicates that the corresponding requirement is not invoked in the current stage, Level 1 indicates a weak requirement, Level 2 indicates that the corresponding performance is significantly involved in the current stage, and Level 3 indicates that the corresponding performance is the main requirement in the current stage.

[0143] This embodiment first uses autonomous directional propulsion as the initial operation process.

[0144] During autonomous orientation propulsion, greater reliance is needed on the endotracheal tube's own orientation-maintaining capabilities. Therefore, the orientation and navigation requirements at each stage are increased by one level, while the channel passage requirements and bending adaptation requirements remain unchanged.

[0145] After the demand was revised, the amplitude was limited according to the range of level 0 to level 3, resulting in:

[0146] Subsequently, based on the performance deviation status obtained in Example 1, the actual performance of each batch was scored from level 0 to level 3.

[0147] For performance quantities whose values ​​decrease in a favorable direction, according to the normalized performance offset Advantages in computing performance:

[0148] For performance quantities whose values ​​increase in a favorable direction:

[0149] Since the performance parameters are favorable for the near-reference bending state, this embodiment does not set separate reference bending states for the three operation stages. Therefore, the design bending radius of the same specification product in Embodiment 1 is used as the default reference value for all three operation stages.

[0150] Right now:

[0151] The product's bending radius is within the factory-permitted range.

[0152] For the actual bending radius In this case, the performance advantage is:

[0153] for In this case, the performance advantage is:

[0154] All performance benefits are limited to the range of 0 to 1.

[0155] Furthermore, the actual performance score is generated according to the following fixed thresholds:

[0156] First, calculate batch A.

[0157] In Example 1, the outer diameter performance deviation of batch A is approximately:

[0158] Since a smaller outer diameter facilitates passage through the channel, therefore:

[0159] The corresponding actual performance rating is level 3.

[0160] The stiffness performance deviation of batch A is approximately:

[0161] For passageways and bending adaptations, stiffness reduction is in a favorable direction, therefore:

[0162] The corresponding actual performance rating is level 3.

[0163] For directional navigation, increased stiffness is advantageous in certain directions, therefore:

[0164] The corresponding actual performance rating is 0.

[0165] The actual bending radius of batch A is 130 mm, which is smaller than the reference bending radius of 140 mm. Therefore:

[0166] The corresponding actual performance rating is Level 2.

[0167] Therefore, for batch A, the channel meets the requirements for both outer diameter and stiffness evaluation values. Taking the lowest value of the two scores, we obtain:

[0168] The bending adaptation requirements correspond to the evaluation quantities of bending radius and stiffness:

[0169] The required bending radius and stiffness for directional navigation are as follows:

[0170] Therefore, batch A exhibits high channel throughput performance, moderate bending adaptability, and low autonomous orientation navigation performance.

[0171] The actual performance scores mentioned above are compared with the revised demand levels for the three operational phases.

[0172] In the first operational phase:

[0173] Among them, the risk of passage is 0, the risk of bending adaptation is 0, and the risk of directional navigation is 2.

[0174] In the second operational phase:

[0175] In the third operational phase:

[0176] Thus, batch A forms an initial risk sequence under autonomous directional propulsion conditions:

[0177] This risk sequence indicates that the lower outer diameter and lower tube stiffness of batch A are beneficial for passage and bending adaptation, but the same lower stiffness also makes it more prone to directional navigation risks during autonomous directional propulsion.

[0178] Furthermore, batch B was evaluated.

[0179] The outer diameter offset of batch B is 0, therefore, when the outer diameter decreases in a favorable direction:

[0180] The corresponding actual performance rating is Level 2.

[0181] The stiffness offset of batch B is 0, therefore, the following applies when stiffness decreases in a favorable direction and when stiffness increases in a favorable direction:

[0182] The corresponding actual performance ratings are all level 2.

[0183] The actual bending radius of batch B is 141 mm, which is greater than the reference bending radius of 140 mm. Therefore:

[0184] The corresponding actual performance rating is level 3.

[0185] thus:

[0186]

[0187]

[0188] Therefore, under autonomous directional propulsion conditions, the three operational stages of batch B are respectively formed as follows:

[0189]

[0190]

[0191] This yields the initial risk sequence for batch B:

[0192] Furthermore, batch C was evaluated.

[0193] The outer diameter offset of batch C is 0.533. Reducing the outer diameter is advantageous, therefore:

[0194] The corresponding actual performance rating is 0.

[0195] The stiffness offset for batch C is 0.594. For passageway and bending adaptation, a reduction in stiffness is advantageous.

[0196] The corresponding actual performance rating is 0.

[0197] For directional navigation, increased stiffness is advantageous:

[0198] The corresponding actual performance rating is level 3.

[0199] The actual bending radius of batch C is 152 mm, which is greater than the reference bending radius of 140 mm. Therefore:

[0200] The corresponding actual performance rating is Level 1.

[0201] thus:

[0202]

[0203]

[0204] The initial risks corresponding to the three operational phases are as follows:

[0205]

[0206]

[0207] This yields the initial risk sequence for batch C:

[0208] Through the above calculations, assuming all products are qualified, batch performance discretization within the manufacturing tolerance range, which was originally not used to differentiate applications, can be converted into risk differences under specific applications and operational stages.

[0209] This embodiment ultimately outputs the initial risk sequences of batches A, B, and C under conditions of oral cannulation and autonomous directional propulsion. Example 3

[0210] This embodiment builds upon the initial risk sequence of batches A, B, and C established in Embodiment 2, and develops usage guidelines for each production batch for both oral and nasal intubation applications. The two applications are initially evaluated independently, without one application's evaluation result replacing the other's usage guidelines. Once the usage methods, residual risks, and handling burdens for both applications are determined, prioritization is further established only when there is a need for batch selection or application allocation.

[0211] In this embodiment, softening is considered a pre-operation process, pre-shaping is also included in the pre-operation process, and guidance assistance is included in the operation process.

[0212] For the softening process, this embodiment uses a pre-calibrated heat softening method, placing the endotracheal tube to be treated in... Treat in warm saline solution for 10 minutes. Based on pre-calibration records of representative products from the same product line and with the same nominal specifications, the unsoftened state is recorded as... Stiffness correction factor The softening state after 10 minutes is recorded as follows: The stiffness correction factor was obtained by calibration. .

[0213] therefore:

[0214]

[0215] in:

[0216] in The softening process time is indicated. In this embodiment, based on the pre-operation timing record, a pre-determined 25-second pre-operation processing time is added, and a 15-second operation process processing time is added for guidance and assistance.

[0217]

[0218] For any usage method:

[0219]

[0220]

[0221] When selecting usage methods within the same batch and for the same purpose, the maximum residual risk should be compared first. Then compare the cumulative remaining risk If both are the same, then compare them. and Therefore, processing time is not used to gain higher residual risk.

[0222] I. Usage methods for oral intubation Example 2 yielded the following initial risk sequence for batch A under conditions of transoral cannulation and autonomous directional propulsion:

[0223] The maximum initial risk is 3, and the cumulative initial risk is 9.

[0224] The original stiffness evaluation value for batch A is:

[0225] After softening for 10 minutes:

[0226] Batch A's original stiffness was already at the lower end of the design range; further softening would not improve its directional navigation performance, and its bending adaptation score remained limited by the actual bending radius. Therefore, the three actual performance scores before and after softening remained unchanged. .

[0227] Combining autonomous directional propulsion, pre-shaping, and guidance assistance in the unsoftened and 10-minute softened states respectively yielded:

[0228] Therefore, batch A, when used for oral cannulation, was made with unsoftened and pre-shaped material. Its revised risk sequence is:

[0229] therefore:

[0230]

[0231] The initial risk sequence for oral intubation in batch B is as follows:

[0232] Its maximum initial risk is 1, and its cumulative initial risk is 4.

[0233] The initial stiffness evaluation value for batch B is 1.000. After softening for 10 minutes:

[0234] Based on the allowable lower limit of stiffness of 0.792:

[0235] After softening, the stiffness score for directional navigation decreased from level 2 to level 1. The candidate methods are as follows:

[0236] Therefore, when batch B is used for transoral cannulation, it is unsoftened and pre-shaped, and the revised risk sequence is:

[0237] get:

[0238]

[0239] The initial risk sequence for oral intubation in batch C is as follows:

[0240] The maximum initial risk is 3, and the cumulative initial risk is 17.

[0241] The original stiffness evaluation value of batch C is 1.156. After softening for 10 minutes:

[0242] Based on the upper limit of stiffness evaluation value of 1.263:

[0243] When stiffness decreases in a favorable direction:

[0244] Corresponding to Level 1 actual performance rating; when stiffness increase is in a favorable direction:

[0245] This corresponds to a Level 2 actual performance rating. Combining the outer diameter and bending radius ratings, the softened channel passage, bending adaptation, and directional navigation actual performance ratings are: .

[0246] The candidate methods are as follows:

[0247] Therefore, when batch C is used for oral cannulation, it is softened and pre-shaped for 10 minutes, and its corrected risk sequence is as follows:

[0248] get:

[0249]

[0250] Thus far, only three batches have been identified as having been used for oral intubation, and their use for nasal intubation is not excluded based on this.

[0251] II. Usage of nasal intubation In this embodiment, the basic requirements for the three stages of nasal intubation are configured as follows:

[0252] The calculation was performed using the same finite candidate method as for transoral intubation.

[0253] For batch A, the actual performance scores before and after softening were both... :

[0254] Therefore, when batch A is used for nasal intubation, it is unsoftened and pre-shaped, and the revised risk sequence is:

[0255] get:

[0256]

[0257] For batch B, the actual performance score in the unsoftened state is: After softening, it becomes :

[0258] Therefore, when batch B is used for nasal intubation, it is unsoftened and pre-shaped, and the revised risk sequence is:

[0259] get:

[0260]

[0261] For batch C, the actual performance score in the unsoftened state is: After softening for 10 minutes, it becomes :

[0262] Therefore, when batch C is used for nasal intubation, it is softened and pre-shaped for 10 minutes. The revised risk sequence is as follows:

[0263] get:

[0264]

[0265] Therefore, usage instructions for the three production batches were developed for two different purposes:

[0266] This table shows how each qualified production batch is used in two different applications, and provides guidance on removing one application from the list if it is deemed superior.

[0267] III. Risk Changes Following Missing or Missing Processes Furthermore, each of the above-mentioned treatments for each use method is cancelled one by one, while the remaining treatments remain unchanged, and the risk sequence is recalculated.

[0268] For the oral cannulation method of batch A, if pre-defined procedures are lacking and the original autonomous directional propulsion process is not restored, the risk sequence is as follows:

[0269] It becomes:

[0270] This means the maximum residual risk increases from level 2 to level 3, and the cumulative residual risk increases from 3 to 9. Although this can reduce the pre-operation processing time by 25 seconds, it also increases the directional navigation risk by level 2 during the restricted passage phase, the bending adaptation risk by level 1 and the directional navigation risk by level 2 during the direction adjustment phase, and the directional navigation risk by level 1 during the target position advancement phase.

[0271] For the nasal intubation procedure of batch A, if a pre-defined protocol is lacking, the risk sequence is as follows:

[0272] It becomes:

[0273] The maximum residual risk is increased from level 1 to level 3, and the cumulative residual risk is increased from 2 to 10, which can reduce the pre-operation time by 25 seconds.

[0274] For the oral cannulation procedure of batch B, if a pre-defined protocol is lacking, the risk sequence is restored as follows:

[0275] The maximum residual risk remains at level 1, but the cumulative residual risk increases from 1 to 4, mainly due to the increased bending adaptation and directional navigation risks during the direction adjustment phase, as well as the directional navigation risks during the target position advancement phase.

[0276] For the nasal intubation procedure of batch B, if a pre-defined protocol is lacking, the risk sequence becomes:

[0277] The maximum residual risk remains at level 1, while the cumulative residual risk increases from 1 to 5, which can reduce the pre-operation processing time by 25 seconds. However, it adds a level 1 bending adaptation risk during the restricted channel phase, a level 1 bending adaptation risk and a level 1 orientation navigation risk during the direction adjustment phase, and a level 1 orientation navigation risk during the target position advancement phase.

[0278] Batch C included 10 minutes of softening and pre-setting in both applications, so the results were evaluated separately for the absence of the two treatments.

[0279] When batch C is used for oral intubation, the complete risk sequence for its use is as follows:

[0280] If softening is not performed but the pre-defined pattern is retained, the risk sequence is as follows:

[0281] The maximum residual risk remains at level 3, while the cumulative residual risk increases from 7 to 10. Omitting softening can reduce the pre-operation time by 600 s, but the bending adaptation risk in all three operation stages increases by 1 level.

[0282] If softening is retained but pre-shaping is not performed, and the autonomous directional propulsion process is resumed, then the risk sequence is:

[0283] The cumulative remaining risk increases from 7 to 14. Omitting the pre-determined configuration only reduces the pre-operation time by 25 seconds, but it increases the bending adaptation risk and orientation navigation risk during the restricted passage phase, the direction adjustment phase increases the level 1 bending adaptation risk and level 2 orientation navigation risk, and the target position advancement phase increases the level 1 bending adaptation risk and level 1 orientation navigation risk.

[0284] When batch C is used for nasal intubation, the complete risk sequence for this method of use is as follows:

[0285] If softening is not performed but the pre-defined pattern is retained, the risk sequence is as follows:

[0286] The cumulative remaining risk increased from 8 to 11, the bending adaptation risk of each of the three operation stages increased by 1 level, and the pre-operation time was reduced by 600 s.

[0287] If softening is retained but not pre-defined, the risk sequence is:

[0288] The cumulative remaining risk increased from 8 to 16, reducing the pre-operation time by only 25 seconds, but the directional navigation risk increased significantly during both the direction adjustment phase and the target position advancement phase.

[0289] Therefore, the impact of handling missing information can be summarized as follows:

[0290] Based on the above results, the usage guidelines not only provide what additional processing should be done for the current batch under the current purpose and the time required for processing, but also provide the specific risks that will be incurred if the corresponding processing is omitted. This allows us to distinguish between the time burden that can be arranged in advance and the risk improvement effect corresponding to that time burden.

[0291] IV. Priority when there is a need to choose Once the usage guidelines for the aforementioned two purposes are formulated, they do not necessarily need to be ranked in order of purpose.

[0292] When the actual task has been determined to be oral intubation, and batches A, B, and C are all available, based on the results of each batch under oral intubation, the maximum residual risk, cumulative residual risk, and processing burden are compared sequentially to obtain:

[0293] When the actual task has been determined to be nasal intubation, the same result is obtained:

[0294] Both batch B and batch A have a maximum residual risk of level 1 under nasal intubation, but the cumulative residual risk of batch B is 1, which is less than that of batch A (2). Therefore, batch B takes precedence over batch A in this application.

[0295] Furthermore, the comparison of the two intended uses already established for that batch is only made when there is a genuine need to prioritize the allocation of two uses within the same production batch. The results for nasal cannulation in batch A are as follows: , The results were better than those from oral intubation. , Batch B showed the same results for both applications; Batch C had a maximum residual risk of 3 for both applications, but the cumulative residual risk for oral intubation was 7, which was less than the 8 for nasal intubation.

[0296] Therefore, when there is a genuine need for allocation, batch A can be prioritized for nasal intubation, batch B has no priority for either use, and batch C can be prioritized for oral intubation.

Claims

1. A method for detecting risks during endotracheal intubation, characterized in that, include: S1: Obtain the actual outer diameter, actual bending radius, and tube stiffness evaluation values ​​of multiple qualified production batches of the same product line and the same nominal specification to form batch performance data for each production batch. S2, based on the product setting values ​​and allowable tolerances for each performance level, convert the batch performance data into a performance deviation state relative to the design state; S3, divide the operation into stages for each optional purpose, configure channel passage requirements, bending adaptation requirements and directional navigation requirements for each operation stage, convert the performance deviation state into a performance score according to the performance items and favorable directions corresponding to each requirement, and form an operation risk sequence according to the deficiency of the requirement level and the performance score. S4. Generate a limited set of usage modification schemes based on the operational risk sequence, recalculate the operational risk for each modification scheme, and determine the usage method of each production batch under each optional purpose based on the maximum residual risk, cumulative residual risk, and processing burden. S5, for each production batch under each optional use, a usage guide is formed, including the risk occurrence stage, usage method correction, processing time and remaining risk after correction, and the operational risk is recalculated by canceling the usage method correction in the usage method to obtain the risk change after the corresponding correction is missing; When there is a need for batch selection or usage allocation, the priority of use should be determined according to the usage guidelines for each purpose.

2. The method for detecting risks during endotracheal intubation according to claim 1, characterized in that, In S1, the Shore A hardness of the raw material is converted into the equivalent elastic modulus, and the tube stiffness evaluation quantity is determined based on the equivalent elastic modulus, the actual outer diameter, and the actual inner diameter relative to the cross-sectional bending stiffness in the design state; the performance of each property within the same production batch is statistically analyzed, and the obtained representative values ​​are used to form batch performance data.

3. The method for detecting risks during endotracheal intubation according to claim 1, characterized in that, In S2, for any energy Based on product settings Qualified lower limit and the upper limit of qualification Establish a fixed evaluation standard; when hour, ,when hour, The obtained normalized performance offset This results in the aforementioned performance deviation state.

4. The method for detecting risks during endotracheal intubation according to claim 1, characterized in that, In S3, a decrease in the actual outer diameter and a decrease in the pipe stiffness evaluation value are mapped to favorable directions for channel passage. A decrease in the pipe stiffness evaluation value and a near-reference bending radius are mapped to favorable directions for bending adaptation. An increase in the pipe stiffness evaluation value and a near-reference bending radius are mapped to favorable directions for directional navigation. Performance scores are generated based on performance deviations and favorable directions; when the same requirement corresponds to multiple performance items, the lowest performance score is taken. and in accordance with Identify operational risks, including This corresponds to the required level for the corresponding operational stage.

5. The method for detecting risks during endotracheal intubation according to claim 1, characterized in that, In S4, the channel is softened by risk, the bending adaptation risk is softened or shaped by assistance, and the directional navigation risk is shaped or guided by assistance. For non-mutually exclusive modifications, a limited combination is made. The softening treatment corrects the tube stiffness evaluation quantity according to the pre-calibrated relationship between the processing time and the stiffness correction coefficient. The risk of each combination is recalculated, and the usage method is determined in sequence based on the maximum residual risk, the cumulative residual risk, the processing time of the operation process, and the total processing burden.

6. The method for detecting risks during endotracheal intubation according to claim 1, characterized in that, In S5, the method modification is divided into pre-operation processing and operation process processing; one method modification is cancelled item by item and the risk is recalculated, and the risk stage, risk type, risk level and reduction of processing time after the modification is missing are output; Only when there is a need for batch selection or usage allocation should the priority of use be determined according to the maximum residual risk, cumulative residual risk, operation process time and total processing burden.

7. A risk guidance system for endotracheal intubation procedures, characterized in that, The system includes a processor and a memory, the memory storing a computer program that, when executed by the processor, causes the system to perform the endotracheal intubation operation risk detection method according to any one of claims 1 to 6, so as to form usage guidelines for each production batch under each optional use, and to form a corresponding usage priority order when there is a batch selection or use allocation requirement.